听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览BLOOD期刊下所有文献
  • Exposure of plasminogen and a novel plasminogen receptor, Plg-RKT, on activated human and murine platelets.

    abstract::Plasminogen activation rates are enhanced by cell surface binding. We previously demonstrated that exogenous plasminogen binds to phosphatidylserine-exposing and spread platelets. Platelets contain plasminogen in their α-granules, but secretion of plasminogen from platelets has not been studied. Recently, a novel tran...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020007263

    authors: Whyte CS,Morrow GB,Baik N,Booth NA,Jalal MM,Parmer RJ,Miles LA,Mutch NJ

    更新日期:2021-01-14 00:00:00

  • Tissue factor pathway inhibitor is required for cerebrovascular development in mice.

    abstract::Tissue factor pathway inhibitor (TFPI) inhibits proteases in the blood coagulation cascade that lead to the production of thrombin, including prothrombinase (factor Xa [FXa]/FVa), the catalytic complex that directly generates thrombin. Thus, TFPI and FV are directly linked in regulating the procoagulant response. Stud...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020006054

    authors: Maroney SA,Westrick RJ,Cleuren AC,Martinez ND,Siebert AE,Zogg M,Ginsburg D,Weiler H,Mast AE

    更新日期:2021-01-14 00:00:00

  • Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI.

    abstract::Graft-versus-host disease (GVHD) is a prominent barrier to allogeneic hematopoietic stem cell transplantation (AHSCT). Definitive diagnosis of GVHD is invasive, and biopsies of involved tissues pose a high risk of bleeding and infection. T cells are central to GVHD pathogenesis, and our previous studies in a chronic G...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005770

    authors: Assmann JC,Farthing DE,Saito K,Maglakelidze N,Oliver B,Warrick KA,Sourbier C,Ricketts CJ,Meyer TJ,Pavletic SZ,Linehan WM,Krishna MC,Gress RE,Buxbaum NP

    更新日期:2021-01-07 00:00:00

  • Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis.

    abstract::Adult-onset hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening disease of immune hyperactivation. Unlike pediatric HLH, adult HLH is rarely driven by germline genetic variants. Although numerous precipitating etiologies have been identified, the reason that HLH occurs in only a subset of individuals ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020008206

    authors: Miller PG,Sperling AS,Gibson CJ,Viswanathan K,Castellano C,McConkey M,Ceremsak J,Taylor MS,Birndt S,Perner F,Arnason J,Agrawal M,Schram AM,Nikiforow S,Pihan G,Hasserjian RP,Aster JC,La Rosée P,Morgan EA,Berliner N,

    更新日期:2020-12-24 00:00:00

  • Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome.

    abstract::Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare primary immunodeficiency caused by gain-of-function mutations in the CXCR4 gene. We report the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of mavorixafor from a phase 2 open-label dose-escalatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020007197

    authors: Dale DC,Firkin F,Bolyard AA,Kelley M,Makaryan V,Gorelick KJ,Ebrahim T,Garg V,Tang W,Jiang H,Skerlj R,Beaussant Cohen S

    更新日期:2020-12-24 00:00:00

  • Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment.

    abstract::Natural killer (NK) cells play critical roles in protection against hematological malignancies but can acquire a dysfunctional state, which limits antitumor immunity. However, the underlying reasons for this impaired NK cell function remain to be uncovered. We found that NK cells in aggressive B-cell lymphoma underwen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005602

    authors: Kobayashi T,Lam PY,Jiang H,Bednarska K,Gloury R,Murigneux V,Tay J,Jacquelot N,Li R,Tuong ZK,Leggatt GR,Gandhi MK,Hill MM,Belz GT,Ngo S,Kallies A,Mattarollo SR

    更新日期:2020-12-24 00:00:00

  • The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.

    abstract::Numerous studies have reported significant associations between ABO blood group and risk of cardiovascular disease. These studies have consistently demonstrated that thrombotic risk is significantly reduced in individuals in blood group O. Nevertheless, the biological mechanisms through which ABO influences hemostasis...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005843

    authors: Ward SE,O'Sullivan JM,O'Donnell JS

    更新日期:2020-12-17 00:00:00

  • How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.

    abstract::Hematopoietic transplantation is the preferred treatment for many patients with hematologic malignancies. Some patients may develop invasive fungal diseases (IFDs) during initial chemotherapy, which need to be considered when assessing patients for transplantation and treatment posttransplantation. Given the associate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005884

    authors: Puerta-Alcalde P,Champlin RE,Kontoyiannis DP

    更新日期:2020-12-10 00:00:00

  • Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.

    abstract::Acquired thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease characterized by thrombotic microangiopathy leading to end-organ damage. The standard of care (SOC) treatment is therapeutic plasma exchange (TPE) alongside immunomodulation with steroids, with increasing use of rituximab +/- other immuno...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020006052

    authors: Goshua G,Sinha P,Hendrickson JE,Tormey CA,Bendapudi P,Lee AI

    更新日期:2020-12-06 00:00:00

  • Rapid single-molecule digital detection of protein biomarkers for continuous monitoring of systemic immune disorders.

    abstract::Digital protein assays have great potential to advance immunodiagnostics because of their single-molecule sensitivity, high precision, and robust measurements. However, translating digital protein assays to acute clinical care has been challenging because it requires their deployment with a rapid turnaround. Herein, w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004399

    authors: Song Y,Sandford E,Tian Y,Yin Q,Kozminski AG,Su SH,Cai T,Ye Y,Chung MT,Lindstrom R,Goicochea A,Barabas J,Olesnavich M,Rozwadowski M,Li Y,Alam HB,Singer BH,Ghosh M,Choi SW,Tewari M,Kurabayashi K

    更新日期:2020-12-04 00:00:00

  • Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapy.

    abstract::Adeno-associated virus (AAV)-based gene therapies can restore endogenous factor VIII (FVIII) expression in hemophilia A (HA). AAV vectors typically use a B-domain-deleted FVIII transgene, such as human FVIII-SQ in valoctocogene roxaparvovec (AAV5-FVIII-SQ). Surprisingly, the activity of transgene-produced FVIII-SQ was...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005683

    authors: Rosen S,Tiefenbacher S,Robinson M,Huang M,Srimani J,Mackenzie D,Christianson T,Pasi KJ,Rangarajan S,Symington E,Giermasz A,Pierce GF,Kim B,Zoog SJ,Vettermann C

    更新日期:2020-11-26 00:00:00

  • Increased β4GALT1 expression associates with platelet surface galactosylation and thrombopoietin plasma levels in MPNs.

    abstract::Aberrant megakaryopoiesis is a hallmark of the myeloproliferative neoplasms (MPNs), a group of clonal haematological malignancies originating from haematopoietic stem cells, leading to an increase in mature blood cells in the peripheral blood. Sialylated derivatives of the glycan structure β4-N-acetyllactosamine (Galβ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020007265

    authors: Di Buduo CA,Giannini S,Abbonante V,Rosti V,Hoffmeister K,Balduini A

    更新日期:2020-11-25 00:00:00

  • Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition.

    abstract::The interaction of menin (MEN1) and MLL (MLL1, KMT2A) is a dependency and provides a potential opportunity for treatment of NPM1-mutant (NPM1mut) and MLL-rearranged (MLL-r) leukemias. Concomitant activating driver mutations in the gene encoding the tyrosine kinase FLT3 occur in both leukemias and are particularly comm...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005037

    authors: Dzama MM,Steiner M,Rausch J,Sasca D,Schönfeld J,Kunz K,Taubert MC,McGeehan GM,Chen CW,Mupo A,Hähnel P,Theobald M,Kindler T,Koche RP,Vassiliou GS,Armstrong SA,Kühn MWM

    更新日期:2020-11-19 00:00:00

  • EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.

    abstract::Primary central nervous system lymphoma (PCNSL) is confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic spread. Rarely, PCNSL occurs in the context of immunosuppression, e.g. post-transplant lymphoproliferative disorders (PTLD) or HIV (AIDS-related PCNSL). These cases are poorly characteri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020008520

    authors: Gandhi MK,Hoang T,Law SC,Brosda S,O'Rourke K,Tobin JWD,Vari F,Murigneux V,Fink JL,Gunawardana J,Gould CM,Oey H,Bednarska K,Delecluse S,Trappe RU,de Long LM,Sabdia MB,Bhagat G,Hapgood G,Blyth E,Clancy LE,Wight J

    更新日期:2020-11-17 00:00:00

  • The treatment of Burkitt lymphoma in adults.

    abstract::Burkitt lymphoma (BL) is a highly aggressive, B-cell, non-Hodgkin lymphoma (NHL) categorized into endemic, sporadic and immunodeficiency-associated subtypes. BL has distinct pathologic and clinical features, characterized by rapidly progressive tumors with high rates of extranodal involvement. Next generation sequenci...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004099

    authors: Crombie JL,LaCasce AS

    更新日期:2020-11-10 00:00:00

  • How I treat lymphoma in pregnancy.

    abstract::Lymphomas afflict all age groups of people, with certain types demonstrating a female predilection in adolescents and young adults. A proportion of lymphomas that are diagnosed in this population demographic occur in the setting of pregnancy. Most of these behave aggressively at presentation and require immediate or u...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000961

    authors: Dunleavy K,McLintock C

    更新日期:2020-11-05 00:00:00

  • Plasmablasts derive from CD23-negative activated B cells after the extinction of IL-4/STAT6 signaling and IRF4 induction.

    abstract::The terminal differentiation of B cells into antibody-secreting cells (ASCs) is a critical component of adaptive immune responses. However, it is a very sensitive process, which dysfunctions lead to a great variety of lymphoproliferative neoplasia including germinal center-derived lymphomas. To better characterize the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005083

    authors: Pignarre A,Chatonnet F,Caron G,Haas M,Desmots-Loyer F,Fest T

    更新日期:2020-11-04 00:00:00

  • Relapse risk following truncation of PEG-asparaginase in childhood acute lymphoblastic leukemia.

    abstract::Truncation of asparaginase treatment due to asparaginase related toxicities or silent inactivation (SI) is common and may increase relapse risk in acute lymphoblastic leukemia (ALL). We investigated relapse risk following suboptimal asparaginase exposure among 1401 children aged 1-17 years, diagnosed with ALL between ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020006583

    authors: Gottschalk Højfeldt S,Grell K,Abrahamsson J,Lund B,Vettenranta K,Jonsson OG,Frandsen TL,Wolthers BO,Marquart HVH,Vaitkeviciene G,Lepik K,Heyman M,Schmiegelow K,Albertsen BK

    更新日期:2020-11-04 00:00:00

  • Hepatosplenic T-cell lymphoma: a rare but challenging entity.

    abstract::Hepatosplenic T-cell lymphoma (HSTCL) is a rare T-cell neoplasm that most commonly arises from a small subset of γ/δ T-cell receptor-expressing lymphocytes. HSTCL is more common in adolescent and young adults and has a rapidly progressive clinical course and poor outcome due to its refractoriness to conventional chemo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004118

    authors: Pro B,Allen P,Behdad A

    更新日期:2020-10-29 00:00:00

  • Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.

    abstract::Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) that leads to progressive bone marrow (BM) fibrosis. Although the cellular mutations involved in the pathogenesis of PMF have been extensively investigated, the sequential events that drive stromal activation and fibrosis by hematopoietic-stromal cross...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004095

    authors: Gleitz HFE,Dugourd AJF,Leimkühler NB,Snoeren IAM,Fuchs SNR,Menzel S,Ziegler S,Kröger N,Triviai I,Büsche G,Kreipe H,Banjanin B,Pritchard JE,Hoogenboezem R,Bindels EM,Schumacher N,Rose-John S,Elf S,Saez-Rodriguez J,Kr

    更新日期:2020-10-29 00:00:00

  • IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.

    abstract::Anaplastic large cell lymphoma (ALCL) is a T-cell malignancy predominantly driven by a hyperactive anaplastic lymphoma kinase (ALK) fusion protein. ALK inhibitors, such as crizotinib, provide alternatives to standard chemotherapy with reduced toxicity and side effects. Children with lymphomas driven by nucleophosmin 1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003793

    authors: Prokoph N,Probst NA,Lee LC,Monahan JM,Matthews JD,Liang HC,Bahnsen K,Montes-Mojarro IA,Karaca-Atabay E,Sharma GG,Malik V,Larose H,Forde SD,Ducray SP,Lobello C,Wang Q,Luan SL,Pospíšilová Š,Gambacorti-Passerini C,Burk

    更新日期:2020-10-01 00:00:00

  • HHEX promotes myeloid transformation in cooperation with mutant ASXL1.

    abstract::Additional sex combs-like 1 (ASXL1), an epigenetic modulator, is frequently mutated in myeloid neoplasms. Recent analyses of mutant ASXL1 conditional knockin (ASXL1-MT-KI) mice suggested that ASXL1-MT alone is insufficient for myeloid transformation. In our previous study, we used retrovirus-mediated insertional mutag...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004613

    authors: Takeda R,Asada S,Park SJ,Yokoyama A,Becker HJ,Kanai A,Visconte V,Hershberger C,Hayashi Y,Yonezawa T,Tamura M,Fukushima T,Tanaka Y,Fukuyama T,Matsumoto A,Yamasaki S,Nakai K,Yamazaki S,Inaba T,Shibata T,Inoue D,Ho

    更新日期:2020-10-01 00:00:00

  • Repurposing a novel anti-cancer RXR agonist to attenuate acute GVHD and maintain graft-versus-leukemia responses.

    abstract::The nuclear receptors (NR) retinoid X receptors (RXRs) exert immunomodulatory functions to control inflammation and metabolism via homodimers and heterodimers with several other NRs including retinoic acid receptors. IRX4204 is a novel, highly specific RXR agonist in clinical trials that potently and selectively activ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005628

    authors: Thangavelu G,Wang C,Loschi M,Saha A,Osborn M,Furlan SN,Aoyama K,McDonald-Hyman C,Aguilar EG,Janesick AS,Chandraratna RA,Refaeli Y,Panoskaltsis-Mortari A,MacDonald KP,Hill GR,Zeiser R,Maillard I,Serody J,Murphy WJ,Mu

    更新日期:2020-09-24 00:00:00

  • Macrophage metabolic adaptation to heme detoxification involves CO-dependent activation of the pentose phosphate pathway.

    abstract::Heme is an essential cofactor for numerous cellular functions, but release of free heme during hemolysis results in oxidative tissue damage, vascular dysfunction, and inflammation. Macrophages play a key protective role in heme clearance; however, the mechanisms that regulate metabolic adaptations that are required fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020004964

    authors: Bories GFP,Yeudall S,Serbulea V,Fox TE,Isakson BE,Leitinger N

    更新日期:2020-09-24 00:00:00

  • piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL.

    abstract::The initiation and progression of diffuse large B-cell lymphoma (DLBCL) is governed by genetic and epigenetic aberrations. As the most abundant eukaryotic message RNA modification, N6-methyladenosine (m6A) is known to influence various fundamental bioprocesses by regulating target gene; however, the function of m6A mo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003764

    authors: Han H,Fan G,Song S,Jiang Y,Qian C,Zhang W,Su Q,Xue X,Zhuang W,Li B

    更新日期:2020-09-23 00:00:00

  • Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.

    abstract::Mantle cell lymphoma (MCL) is a mature B-cell neoplasm initially driven by CCND1 rearrangement with 2 molecular subtypes, conventional MCL (cMCL) and leukemic non-nodal MCL (nnMCL), that differ in their clinicobiological behavior. To identify the genetic and epigenetic alterations determining this diversity, we used w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005289

    authors: Nadeu F,Martin-Garcia D,Clot G,Díaz-Navarro A,Duran-Ferrer M,Navarro A,Vilarrasa-Blasi R,Kulis M,Royo R,Gutiérrez-Abril J,Valdés-Mas R,López C,Chapaprieta V,Puiggros M,Castellano G,Costa D,Aymerich M,Jares P,Espinet B

    更新日期:2020-09-17 00:00:00

  • Specialized regulatory T cells control venous blood clot resolution through SPARC.

    abstract::The cells and mechanisms involved in blood clot resorption are only partially known. We show that regulatory T (Treg) cells accumulate in venous blood clots and regulate thrombolysis by controlling the recruitment, differentiation and matrix metalloproteinase (MMP) activity of monocytes. We describe a clot Treg popula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005407

    authors: Shahneh F,Alexandra G,Klein M,Frauhammer F,Bopp T,Schäfer K,Raker V,Becker C

    更新日期:2020-09-15 00:00:00

  • Congenital dyserythropoietic anemias.

    abstract::Congenital dyserythropoietic anemias (CDAs) are a heterogeneous group of inherited anemias that affect the normal differentiation-proliferation pathways of the erythroid lineage. They belong to the wide group of ineffective erythropoiesis conditions that mainly result in monolinear cytopenia. CDAs are classified into ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000948

    authors: Iolascon A,Andolfo I,Russo R

    更新日期:2020-09-10 00:00:00

  • Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia.

    abstract::T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy that accounts for ∼20% of ALL cases. Intensive chemotherapy regimens result in cure rates >85% in children and <50% in adults, warranting a search of novel therapeutic strategies. Although immune-based therapies have tremendously improved the trea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003801

    authors: Tran Quang C,Zaniboni B,Humeau R,Lengliné E,Dourthe ME,Ganesan R,Singh S,Scheer JM,Asnafi V,Ghysdael J

    更新日期:2020-09-10 00:00:00

  • Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in Folliculin Interacting Protein 1 deficiency.

    abstract::Agammaglobulinemia is the most profound primary antibody deficiency that can occur due to an early termination of B-cell development. We here investigated 3 novel patients, including the first known adult, from unrelated families with agammaglobulinemia, recurrent infections, and hypertrophic cardiomyopathy (HCM). Two...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020006441

    authors: Saettini F,Poli C,Vengoechea J,Bonanomi S,Orellana JC,Fazio G,Rodriguez FH,Noguera LP,Booth CA,Jarur-Chamy V,Shams M,Iascone M,Vukic M,Gasperini S,Quadri M,Barroeta Seijas AB,Rivers E,Mauri M,Badolato R,Cazzaniga G

    更新日期:2020-09-09 00:00:00

  • How I treat gastrointestinal bleeding in congenital and acquired von Willebrand disease.

    abstract::Gastrointestinal (GI) bleeding is distinctive of severe von Willebrand disease (VWD), generally arising in older patients; in most cases, blood transfusion and hospitalization are required. The presence of arteriovenous malformations is often described when endoscopic examinations are performed. Patients with congenit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003702

    authors: Biguzzi E,Siboni SM,Peyvandi F

    更新日期:2020-09-03 00:00:00

  • A fully human anti-BMP6 antibody reduces the need for erythropoietin in rodent models of the anemia of chronic disease.

    abstract::Recombinant erythropoietin (EPO) and iron substitution are a standard of care for treatment of anemias associated with chronic inflammation, including anemia of chronic kidney disease. A black box warning for EPO therapy and concerns about negative side effects related to high-dose iron supplementation as well as the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004653

    authors: Petzer V,Tymoszuk P,Asshoff M,Carvalho J,Papworth J,Deantonio C,Bayliss L,Wake MS,Seifert M,Brigo N,Valente de Souza L,Hilbe R,Grubwieser P,Demetz E,Dichtl S,Volani C,Berger S,Böhm F,Hoffmann A,Pfeifhofer-Obermair C

    更新日期:2020-08-27 00:00:00

  • Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.

    abstract::Lenalidomide, bortezomib, and dexamethasone (RVd) followed by autologous stem cell transplantation (ASCT) is standard frontline therapy for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). The addition of daratumumab (D) to RVd (D-RVd) in transplant-eligible NDMM patients was evaluated. Patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005288

    authors: Voorhees PM,Kaufman JL,Laubach J,Sborov DW,Reeves B,Rodriguez C,Chari A,Silbermann R,Costa LJ,Anderson LD Jr,Nathwani N,Shah N,Efebera YA,Holstein SA,Costello C,Jakubowiak A,Wildes TM,Orlowski RZ,Shain KH,Cowan AJ,

    更新日期:2020-08-20 00:00:00

  • How I treat cancer-associated anemia.

    abstract::Despite increasing use of targeted therapies to treat cancer, anemia remains a common complication of cancer therapy. Physician concerns about the safety of intravenous (IV) iron products and erythropoiesis-stimulating agents (ESAs) have resulted in many patients with cancer receiving no or suboptimal anemia therapy. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004017

    authors: Gilreath JA,Rodgers GM

    更新日期:2020-08-13 00:00:00

  • Heme induces rapid endothelial barrier dysfunction via the MKK3/p38MAPK axis.

    abstract::Several studies demonstrate that hemolysis and free heme in circulation cause endothelial barrier dysfunction and are associated with severe pathological conditions such as acute respiratory distress syndrome, acute chest syndrome, and sepsis. However, the precise molecular mechanisms involved in the pathology of heme...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003986

    authors: James J,Srivastava A,Varghese MV,Eccles CA,Zemskova M,Rafikova O,Rafikov R

    更新日期:2020-08-06 00:00:00

  • Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

    abstract::Acute erythroleukemia (AEL or acute myeloid leukemia [AML]-M6) is a rare but aggressive hematologic malignancy. Previous studies showed that AEL leukemic cells often carry complex karyotypes and mutations in known AML-associated oncogenes. To better define the underlying molecular mechanisms driving the erythroid phen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003062

    authors: Fagnan A,Bagger FO,Piqué-Borràs MR,Ignacimouttou C,Caulier A,Lopez CK,Robert E,Uzan B,Gelsi-Boyer V,Aid Z,Thirant C,Moll U,Tauchmann S,Kurtovic-Kozaric A,Maciejewski J,Dierks C,Spinelli O,Salmoiraghi S,Pabst T,Shimo

    更新日期:2020-08-06 00:00:00

  • SLFN11 promotes stalled fork degradation that underlies the phenotype in Fanconi anemia cells.

    abstract::Fanconi anemia (FA) is a hereditary disorder caused by mutations in any 1 of 22 FA genes. The disease is characterized by hypersensitivity to interstrand crosslink (ICL) inducers such as mitomycin C (MMC). In addition to promoting ICL repair, FA proteins such as RAD51, BRCA2, or FANCD2 protect stalled replication fork...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003782

    authors: Okamoto Y,Abe M,Mu A,Tempaku Y,Rogers CB,Mochizuki AL,Katsuki Y,Kanemaki MT,Takaori-Kondo A,Sobeck AT,Bielinsky AK,Takata M

    更新日期:2020-07-31 00:00:00

  • Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.

    abstract::We developed a risk score to predict event-free survival (EFS) after allogeneic hematopoietic cell transplantation for sickle cell disease. The study population (n = 1425) was randomly split into training (n = 1070) and validation (n = 355) cohorts. Risk factors were identified and validated via Cox regression models....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005687

    authors: Brazauskas R,Scigliuolo GM,Wang HL,Cappelli B,Ruggeri A,Fitzhugh CD,Hankins JS,Kanter J,Meerpohl JJ,Panepinto JA,Rondelli D,Shenoy S,Walters MC,Wagner JE,Tisdale JF,Gluckman E,Eapen M

    更新日期:2020-07-30 00:00:00

  • Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance.

    abstract::The success of allogeneic hematopoietic cell transplantation depends heavily on the delicate balance between the activity of the donor immune system against malignant and nonmalignant cells of the recipient. Abrogation of alloreactivity will lead to disease relapse, whereas untamed allo-immune responses will lead to l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000951

    authors: Voermans C,Hazenberg MD

    更新日期:2020-07-23 00:00:00

  • An evolutionarily ancient mechanism for regulation of hemoglobin expression in vertebrate red cells.

    abstract::The oxygen transport function of hemoglobin (HB) is thought to have arisen ∼500 million years ago, roughly coinciding with the divergence between jawless (Agnatha) and jawed (Gnathostomata) vertebrates. Intriguingly, extant HBs of jawless and jawed vertebrates were shown to have evolved twice, and independently, from ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020004826

    authors: Miyata M,Gillemans N,Hockman D,Demmers JAA,Cheng JF,Hou J,Salminen M,Fisher CA,Taylor S,Gibbons RJ,Ganis JJ,Zon LI,Grosveld F,Mulugeta E,Sauka-Spengler T,Higgs DR,Philipsen S

    更新日期:2020-07-16 00:00:00

3689 条记录 1/93 页 « 12345678...9293 »